Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Open-market buy Director bought 25,000 shares at $4.54 ($113,500)
  2. 4 Open-market buy Director bought 501,041 shares at an average $1.08 ($543,100)
  3. 4 Open-market buy Director bought 50,000 shares at $4.26 ($213,165)
  4. 4 Open-market buy Chief Financial Officer bought 7,831 shares at $4.09 ($32,029)
  5. 4 Open-market buy Director bought 50,000 shares at $3.88 ($193,800)
  6. 4 Open-market buy CCO and General Counsel bought 7,400 shares at $4.12 ($30,488)
  7. 4 Open-market buy Director bought 2,000 shares at $4.89 ($9,780)
  8. 4 Open-market buy Chief Technology Officer bought 1,848 shares at an average $4.80 ($8,875)
  9. 4 Open-market buy Chief Technology Officer bought 2,197 shares at an average $4.55 ($9,995)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Option exercise Director acquired 96,349 shares (option exercise)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Former Director bought 41,697 shares at $7.19 ($299,655)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Business Officer bought 6,400 shares at $7.69 ($49,241)
  19. 4 Open-market buy Chief Business Officer bought 4,000 shares at $7.37 ($29,475)
  20. 4 Open-market buy Director bought 2,000 shares at $6.78 ($13,566)

Page 7 of 12 · 230 filings